Albany Molecular Research (AMRI) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Total operating expenses: 168.4M
Today's EPS Names:
ETCC, LEDS, DSNY, More
Financial Fact:
Total operating expenses: 168.4M
Today's EPS Names:
ETCC, LEDS, DSNY, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q3 EPS of $0.17, $0.04 better than the analyst estimate of $0.13. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $160.75 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citizens launches transportation coverage, names FedEx a top large-cap pick
- Loop Industries (LOOP) Misses Q1 EPS by 2c
- Karooooo Q1 2027 results show record subscriber additions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
